HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Omental grafting: a cell-based therapy for blood vessel repair.

Abstract
Clinicians regularly transplant omental pedicles to repair a wide variety of injured tissues, but the basic mechanism underlying this efficacious procedure is not understood. One possibility that has not been addressed is the ability of omentum to directly contribute regenerative cells to injured tissues. We hypothesized that if omental progenitor cells could be mobilized to incorporate into damaged tissue, the power of this therapy would be greatly expanded. Labelled omental grafts were transplanted into a murine carotid artery injury model. Selected grafts were treated with thymosin β4 (Tβ4) prior to transplantation to investigate the effects of chemical potentiation on healing. We found treatment of grafts with Tβ4-induced progenitor cells to fully integrate into the wall of injured vessels and differentiate into vascular smooth muscle. Myographic studies determined that arteries receiving Tβ4-stimulated grafts were functionally indistinguishable from uninjured controls. Concurrent in vitro analyses showed that Tβ4 promoted proliferation, migration and trans-differentiation of cells via AKT signalling. This study is the first to demonstrate that omentum can provide progenitor cells for repair, thus revealing a novel and naturally occurring source of vascular smooth muscle for use in cell-based therapies. Furthermore, our data show that this system can be optimized with inducing factors, highlighting a more powerful therapeutic potential than that of its current clinical application. This is a paradigm-setting concept that lays the foundation for the use of chemical genetics to enhance therapeutic outcomes in a myriad of fields.
AuthorsElaine L Shelton, Stanley D Poole, Jeff Reese, David M Bader
JournalJournal of tissue engineering and regenerative medicine (J Tissue Eng Regen Med) Vol. 7 Issue 6 Pg. 421-33 (Jun 2013) ISSN: 1932-7005 [Electronic] England
PMID22318999 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 John Wiley & Sons, Ltd.
Chemical References
  • Biomarkers
  • thymosin beta(4)
  • Thymosin
  • integrin-linked kinase
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
Topics
  • Animals
  • Biomarkers (metabolism)
  • Carotid Artery Injuries (pathology, therapy)
  • Cell Differentiation (drug effects)
  • Cell Lineage (drug effects)
  • Cell Movement (drug effects)
  • Cell Proliferation (drug effects)
  • Cell- and Tissue-Based Therapy
  • Cells, Cultured
  • Disease Models, Animal
  • Endothelial Cells (cytology, drug effects, metabolism)
  • Mice
  • Mice, Inbred ICR
  • Myocytes, Smooth Muscle (cytology)
  • Omentum (cytology, transplantation)
  • Phosphorylation (drug effects)
  • Protein Serine-Threonine Kinases (metabolism)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Stem Cells (cytology, drug effects, enzymology)
  • Thymosin (pharmacology)
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: